# IL1 Inhibition in FOP

> **NCT06724562** · — · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 11 (estimated)

## Conditions studied

- Fibrodysplasia Ossificans Progressiva (FOP)

## Interventions

- **OTHER:** Anti-IL1 Therapy

## Key facts

- **NCT ID:** NCT06724562
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06724562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06724562, "IL1 Inhibition in FOP". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06724562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*